Evolution of the Average Target: West Pharmaceutical Services, Inc.

Evolution of the Average Target - West Pharmaceutical Services, Inc.

Evolution of the Target Price: West Pharmaceutical Services, Inc.

Evolution of the Target Price - West Pharmaceutical Services, Inc.

Changes in Analyst Recommendations: West Pharmaceutical Services, Inc.

f800e1d57ad40898d0.MeDqmcpvQ39NYRiAt4mjqS0DEaSKtzvUp56PshB788c.QK2b644ACEofCyi55fnp01tkIfHy1kq69afpwmg5pa5StYKvg1oMGisXcw~5f80e049e0f0caaa958436d1d4d657fb
10-13 TD Cowen Adjusts Price Target on West Pharmaceutical Services to $420 From $410 MT
10-07 Evercore ISI Adjusts West Pharmaceutical Services Price Target to $440 From $410 MT
10-06 Barclays Raises West Pharmaceutical Services Price Target to $440 From $400, Maintains Overweight Rating MT
09-22 West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says MT
09-22 Morgan Stanley Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $365 MT
09-09 UBS Raises Price Target on West Pharmaceutical Services to $415 From $340, Keeps Buy Rating MT
07-27 Evercore ISI Adjusts PT on West Pharmaceutical Services to $425 From $410, Maintains Outperform Rating MT
07-27 BNP Paribas Adjusts PT on West Pharmaceutical Services to $459 From $447, Maintains Outperform Rating MT
07-24 Jefferies & Co Adjusts West Pharmaceutical Services PT to $410 From $365, Maintains Buy Rating MT
07-24 Rothschild & Co Redburn Adjusts West Pharmaceutical Services PT to $410 From $353, Maintains Buy Rating MT
07-24 Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $420 From $405, Maintains Buy Rating MT
07-20 Stephens Adjusts West Pharmaceutical Services Price Target to $410 From $360, Maintains Overweight Rating MT
07-15 TD Cowen Adjusts Price Target on West Pharmaceutical Services to $410 From $365, Maintains Buy Rating MT
07-13 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
07-13 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
07-09 Morgan Stanley Adjusts Price Target on West Pharmaceutical Services to $365 From $325 MT
07-06 Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $410 From $390 MT
07-02 KeyBanc Adjusts PT on West Pharmaceutical Services to $390 From $350, Maintains Overweight Rating MT
06-09 Barclays Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $310 MT
05-28 Morgan Stanley Adjusts West Pharmaceutical Services PT to $325 From $315, Keeps Equalweight Rating MT
04-24 Stephens Adjusts Price Target on West Pharmaceutical Services to $360 From $320, Maintains Overweight Rating MT
04-24 Deutsche Bank Adjusts West Pharmaceutical Services PT to $340 From $315, Maintains Buy Rating MT
04-24 Rothschild & Co Redburn Adjusts West Pharmaceutical Services Price Target to $353 From $312, Maintains Buy Rating MT
04-24 Jefferies Adjusts West Pharmaceutical Services Price Target to $365 From $295, Maintains Buy Rating MT
04-24 Citigroup Adjusts West Pharmaceutical Services PT to $400 From $375, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+17.23%
+10.79%
+28.76%
+51.22%
+10.11%
+18.9%
+2.75%
+32.57%
+15.56%
Average +20.88%
Weighted average by Cap. +20.70%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
374.65USD
Average target price
412.88USD
Spread / Average Target
+10.20%
High Price Target
459.00USD
Spread / Highest target
+22.51%
Low Price Target
340.00USD
Spread / Lowest Target
-9.25%

Analyst Consensus Detail

Analyst consensus - West Pharmaceutical Services, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - West Pharmaceutical Services, Inc.
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - West Pharmaceutical Services, Inc.
  1. Stock Market
  2. Stocks
  3. WST Stock
  4. WST * Stock
  5. Consensus West Pharmaceutical Services, Inc.